GU Cancers 2025 | The future of mobile testing for prostate cancer screening

Masood Moghul • 13 Feb 2025

GU Cancers 2025

Man Van

Masood Moghul, MBBS, The Royal Marsden NHS Foundation Trust, London, UK, comments on the potential of mobile testing to enhance current screening protocols for prostate cancer detection, particularly in underserved populations. Dr Moghul highlights the importance of integrating mobile testing with existing data, including health economic analysis and polygenic risk scores, to further refine and expand the study’s findings. This interview took place at the ASCO GU Cancers Symposium 2025 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.